早期至中度膝骨关节炎患者半月板同种异体移植的10年生存率与临床改善
该病例系列研究纳入47例Kellgren-Lawrence 2或3级症状性膝骨关节炎患者,评估半月板同种异体移植术后至少10年(11.1±1年)的生存率与临床改善。所有临床评分从基线至末次随访均有统计学显著改善,但末次随访时Lysholm评分较中期随访显著下降;5例再手术为手术失败,15例Lysholm评分<65为临床失败。作者认为,即使对早期至中度膝骨关节炎患者,半月板同种异体移植仍是改善疼痛和功能的有效选择,但需告知患者联合干预可能降低移植物生存率。
要点
- Lysholm评分从术前46.4±17.2改善至中期随访77.7±20.4(P<.001),末次随访降至71±23.3(P=.018)。
- 5例患者再手术为手术失败,15例Lysholm评分<65为临床失败,其中4例同时为手术和临床失败。
- 患者未完全恢复至既往运动水平,作者认为半月板同种异体移植可作为早期至中度膝骨关节炎的补救选择。
核心结论
- 半月板同种异体移植手术已被证明是改善膝骨关节炎关节(Kellgren-Lawrence 2或3级)疼痛和功能的有效选择,尽管长期随访中临床结果出现恶化,但仍获得满意结果。
- 作者认为,基于本研究数据,骨科医生可考虑推荐半月板同种异体移植作为早期至中度膝骨关节炎的补救手术,同时应告知患者联合干预的需求可能降低移植物生存率。
研究设计与样本
- 病例系列研究,证据级别4级。
- 共纳入47例症状性膝骨关节炎(Kellgren-Lawrence 2或3级)并接受半月板同种异体移植的患者(37例男性,10例女性),在基线、5年及至少10年(11.1±1年)末次随访时评估。
- 44例患者既往接受过手术;33例患者需要同期手术,如前交叉韧带重建、截骨术和软骨手术。
主要发现
- 从基线评估至末次随访,所有临床评分均有统计学显著改善。
- Lysholm评分从术前46.4±17.2显著改善至中期随访77.7±20.4(P<.001),末次随访显著下降至71±23.3(P=.018)。
- 视觉模拟疼痛量表、膝关节损伤和骨关节炎结局评分及Tegner评分呈现类似趋势,患者未完全恢复至既往运动水平。
- 5例患者接受再手术并被认定为手术失败,15例患者Lysholm评分<65被认定为临床失败,其中4例同时为手术和临床失败。
关键数值与推荐
- Kellgren-Lawrence 2或3级为纳入的膝骨关节炎分级标准。
- Lysholm评分<65被认定为临床失败。
临床怎么用
- 作者认为,骨科医生可考虑推荐半月板同种异体移植作为早期至中度膝骨关节炎的补救手术,同时应告知患者联合干预的需求可能降低移植物生存率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Meniscal allograft transplantation (MAT) is a viable option for patients experiencing unicompartmental knee pain after total or subtotal meniscectomy. Nonetheless, caution is recommended when suggesting this procedure in the presence of knee osteoarthritis (OA) because of the higher risk of poor survival and outcomes. PURPOSE/HYPOTHESIS: The purpose was to document the long-term survival of MAT performed as a salvage procedure in patients with knee OA. The hypothesis was that MAT would significantly reduce pain and increase the function of the affected joint at a long-term follow-up compared with the preoperative condition, with a low number of failures and knee replacement surgeries. STUDY DESIGN: Case series; Level of evidence, 4. METHODS: A total of 47 patients (37 men and 10 women) with symptomatic knee OA (Kellgren-Lawrence grades 2 or 3) treated with MAT were evaluated at baseline, 5 years, and a minimum 10-year final follow-up (11.1 ± 1 years) using the Lysholm score, the visual analog scale for pain, the Knee injury and Osteoarthritis Outcome Score subscales, and the Tegner score. A total of 44 patients had undergone previous surgeries. Patient satisfaction, revision surgeries, and failures were also recorded. RESULTS: A statistically significant improvement was observed in all clinical scores from the baseline assessment to the final follow-up. The Lysholm score improved significantly from 46.4 ± 17.2 at the preoperative assessment to 77.7 ± 20.4 at the intermediate follow-up (P < .001), with a significant decrease at the final follow-up (71 ± 23.3; P = .018). A similar trend was reported for the visual analog scale scale for pain, Knee injury and Osteoarthritis Outcome Score, and Tegner score, with no complete recovery to the previous sports activity level. A total of 33 patients required concurrent procedures, such as anterior cruciate ligament reconstructions, osteotomies, and cartilage procedures. Five patients underwent reoperation and were considered surgical failures, while 15 patients presented a clinical condition of <65 of the Lysholm score and were considered clinical failures. Among these, 4 patients were considered both surgical and clinical failures. CONCLUSION: MAT surgery has proven to be a valid option for improving pain and function even in OA joints (Kellgren-Lawrence grades 2 or 3), yielding satisfactory results despite a worsening clinical outcome in the long-term follow-up. Therefore, based on the data from this study, orthopaedic surgeons may consider recommending MAT as a salvage procedure even in knees affected by early to moderate OA, while advising patients that the need for combined interventions could potentially reduce graft survival.
引用
- Romandini I, Grassi A, Andrea Lucidi G, et al. 10-Year Survival and Clinical Improvement of Meniscal Allograft Transplantation in Early to Moderate Knee Osteoarthritis. Am J Sports Med. 2024. PMID: 38857030. doi:10.1177/03635465241253849
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。